State of Wisconsin Investment Board’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-550,947
| Closed | -$19M | – | 2047 |
|
|
2020
Q3 | $19M | Buy |
550,947
+480,947
| +687% | +$10.2M | 0.05% | 390 |
|
|
2020
Q2 | $1.17M | Buy |
70,000
+600
| +0.9% | +$10.2K | ﹤0.01% | 1214 |
|
|
2020
Q1 | $1M | Buy |
69,400
+2,800
| +4% | +$71.6K | ﹤0.01% | 1200 |
|
|
2019
Q4 | $2.23M | Hold |
66,600
| – | – | 0.01% | 1122 |
|
|
2019
Q3 | $1.4M | Buy |
66,600
+5,600
| +9% | +$114K | ﹤0.01% | 1074 |
|
|
2019
Q2 | $1.27M | Buy |
61,000
+1,300
| +2% | +$26.8K | ﹤0.01% | 1085 |
|
|
2019
Q1 | $1.33M | Buy |
59,700
+15,300
| +34% | +$360K | ﹤0.01% | 1083 |
|
|
2018
Q4 | $1.06M | Buy |
44,400
+300
| +0.7% | +$7.76K | ﹤0.01% | 1114 |
|
|
2018
Q3 | $1.2M | Hold |
44,100
| – | – | ﹤0.01% | 1150 |
|
|
2018
Q2 | $1.19M | Buy |
44,100
+8,400
| +24% | +$257K | ﹤0.01% | 1112 |
|
|
2018
Q1 | $1.14M | Buy |
35,700
+10,700
| +43% | +$377K | ﹤0.01% | 1093 |
|
|
2017
Q4 | $945K | Hold |
25,000
| – | – | ﹤0.01% | 1131 |
|
|
2017
Q3 | $620K | Hold |
25,000
| – | – | ﹤0.01% | 1232 |
|
|
2017
Q2 | $514K | Buy |
+25,000
| New | +$477K | ﹤0.01% | 1271 |
|
State of Wisconsin Investment Board's AIMT Position: Q4 2020 in Review
State of Wisconsin Investment Board sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 550,947 shares — an estimated $19M sold.
State of Wisconsin Investment Board first reported a position in AIMT in Q2 2017 and held it in 14 quarters. The position peaked at $19M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.
- State of Wisconsin Investment Board reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
- State of Wisconsin Investment Board sold 550,947 Aimmune Therapeutics shares in Q4 2020, an estimated $19M.
- State of Wisconsin Investment Board first reported a position in Aimmune Therapeutics in Q2 2017 and held it in 14 quarters.
- State of Wisconsin Investment Board's Aimmune Therapeutics position peaked at $19M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.
Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.